lucrin pds depot 3.75 mg
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - powder and solvent for suspension for injection - leuprorelin acetate 3.75 mg - leuprorelin - endometriosis prostatic cancer treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.
lucrin pds depot 3.75 mg
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - powder and solvent for suspension for injection - leuprorelin acetate 3.75 mg - leuprorelin - endometriosis prostatic cancer treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.
lucrin depot leuprorelin acetate 3.75mg powder for injection prefilled dual-chamber syringe
abbvie pty ltd - leuprorelin acetate, quantity: 3.75 mg - injection, powder for - excipient ingredients: carmellose sodium; mannitol; polysorbate 80; glacial acetic acid; water for injections
lucrin depot leuprorelin acetate 11.25mg powder for injection prefilled dual-chamber syringe
abbvie pty ltd - leuprorelin acetate, quantity: 11.25 mg - injection, powder for - excipient ingredients: carmellose sodium; polysorbate 80; mannitol; glacial acetic acid; water for injections
lutrate depot 22.5mg powder and solvent for prolonged-release suspension for injection
gp-pharm, s.a - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 22.5mg - hormones and related agents. gonadotropin-releasing hormones analogues - it is indicated for palliative treatment of hormone dependent advanced prostate cancer.
eligard 22.5 mg
kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 22.5 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
eligard 45 mg
kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 45 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
eligard 7.5 mg
kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 7.5 mg - eligard 7.5 mg is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer combination with radiotherapy.
eligard ® powder and solvent for solution for injection 22.5mg
dch auriga singapore - leuprorelin 20.87 mg eqv to leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 22.5 mg - leuprorelin 20.87 mg eqv to leuprorelin acetate 22.5 mg
eligard ® powder and solvent for solution for injection 45mg
dch auriga singapore - leuprorelin 41.7 mg eqv leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 45mg - leuprorelin 41.7 mg eqv leuprorelin acetate 45mg